- Source: Ro60-0175
Ro60-0175 is a drug of the isotryptamine group developed by Hoffmann–La Roche, which has applications in scientific research. It acts as a potent and selective agonist for both the 5-HT2B and 5-HT2C serotonin receptor subtypes, with good selectivity over the closely related 5-HT2A subtype, and little or no affinity at other receptors.
See also
AL-34662
AL-38022A
Ro60-0213
VER-3323
YM-348